Literature DB >> 23474946

Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching.

Daniel S Widmer1, Keith S Hoek1, Phil F Cheng1, Ossia M Eichhoff1, Thomas Biedermann2, Marieke I G Raaijmakers1, Silvio Hemmi3, Reinhard Dummer1, Mitchell P Levesque4.   

Abstract

We have previously reported a model for melanoma progression in which oscillation between melanoma cell phenotypes characterized by invasion or proliferation is fundamental to tumor heterogeneity and disease progression. In this study we examine the possible role of hypoxia as one of the microenvironmental influences driving metastatic progression by promoting a switch from a proliferative to an invasive phenotype. Immunohistochemistry on primary human cutaneous melanoma biopsies showed intratumoral heterogeneity for cells expressing melanocytic markers, and a loss of these markers correlated with hypoxic regions. Furthermore, we show that the downregulation of melanocytic markers is dependent on hypoxia inducible factor 1α (HIF1α), a known regulator of the hypoxic response. In vitro invasion assays showed that a hypoxic environment increases the invasiveness of proliferative melanoma cell cultures in a HIF1α-dependent manner. In contrast, invasive phenotype melanoma cells showed no increase in invasive potential upon exposure to hypoxia. Thus, exposure of proliferative melanoma cells to hypoxic microenvironments is sufficient, in a HIF1α-dependent manner, to downregulate melanocytic marker expression and increase their invasive potential.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23474946     DOI: 10.1038/jid.2013.115

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  56 in total

Review 1.  The role of tumor microenvironment in melanoma therapy resistance.

Authors:  Rajasekharan Somasundaram; Meenhard Herlyn; Stephan N Wagner
Journal:  Melanoma Manag       Date:  2016-02-12

2.  To B-(RAF) or not to be.

Authors:  Reinhard Dummer; Simone M Goldinger; Daniel Widmer; Jil Dreier; Mitchell P Levesque
Journal:  J Invest Dermatol       Date:  2014-05       Impact factor: 8.551

3.  Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A.

Authors:  Hun-Way Hwang; Laura L Baxter; Stacie K Loftus; Julia C Cronin; Niraj S Trivedi; Bhavesh Borate; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-27       Impact factor: 4.693

4.  Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle.

Authors:  Battuya Bayarmagnai; Louisiane Perrin; Kamyar Esmaeili Pourfarhangi; Xavier Graña; Erkan Tüzel; Bojana Gligorijevic
Journal:  J Cell Sci       Date:  2019-10-18       Impact factor: 5.285

Review 5.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

6.  SMAD signaling promotes melanoma metastasis independently of phenotype switching.

Authors:  Eylul Tuncer; Raquel R Calçada; Daniel Zingg; Sandra Varum; Phil Cheng; Sandra N Freiberger; Chu-Xia Deng; Ingo Kleiter; Mitchell P Levesque; Reinhard Dummer; Lukas Sommer
Journal:  J Clin Invest       Date:  2019-04-30       Impact factor: 14.808

7.  HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia.

Authors:  Emilia Licarete; Alina Sesarman; Valentin Florian Rauca; Lavinia Luput; Laura Patras; Manuela Banciu
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

Review 8.  Tumour heterogeneity and metastasis at single-cell resolution.

Authors:  Devon A Lawson; Kai Kessenbrock; Ryan T Davis; Nicholas Pervolarakis; Zena Werb
Journal:  Nat Cell Biol       Date:  2018-11-26       Impact factor: 28.824

Review 9.  Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.

Authors:  S Chouaib; M Z Noman; K Kosmatopoulos; M A Curran
Journal:  Oncogene       Date:  2016-06-27       Impact factor: 9.867

10.  Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

Authors:  Michael P O'Connell; Katie Marchbank; Marie R Webster; Alexander A Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C Camilli; Fred E Indig; Keith T Flaherty; Jennifer A Wargo; Dennie T Frederick; Zachary A Cooper; Suresh Nair; Ravi K Amaravadi; Lynn M Schuchter; Giorgos C Karakousis; Wei Xu; Xiaowei Xu; Ashani T Weeraratna
Journal:  Cancer Discov       Date:  2013-10-08       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.